Vaxxinity, Inc. (VAXX)

USD 0.05

(200.0%)

Net Income Summary of Vaxxinity, Inc.

  • Vaxxinity, Inc.'s latest annual net income in 2023 was -56.93 Thousand USD , up 99.92% from previous year.
  • Vaxxinity, Inc.'s latest quarterly net income in 2023 FY was -56.93 Million USD , up 24.3% from previous quarter.
  • Vaxxinity, Inc. reported an annual net income of -75.21 Million USD in 2022, up 45.51% from previous year.
  • Vaxxinity, Inc. reported an annual net income of -138.01 Million USD in 2021, down -290.13% from previous year.
  • Vaxxinity, Inc. reported a quarterly net income of -13.97 Million USD for 2023 Q2, up 24.08% from previous quarter.
  • Vaxxinity, Inc. reported a quarterly net income of -18.4 Million USD for 2023 Q1, up 10.08% from previous quarter.

Annual Net Income Chart of Vaxxinity, Inc. (2023 - 2019)

Historical Annual Net Income of Vaxxinity, Inc. (2023 - 2019)

Year Net Income Net Income Growth
2023 -56.93 Thousand USD 99.92%
2022 -75.21 Million USD 45.51%
2021 -138.01 Million USD -290.13%
2020 -35.37 Million USD -148.8%
2019 -14.21 Million USD 0.0%

Peer Net Income Comparison of Vaxxinity, Inc.

Name Net Income Net Income Difference
America Great Health -761.42 Thousand USD 92.523%
Ampio Pharmaceuticals, Inc. -8.63 Million USD 99.34%
Aridis Pharmaceuticals, Inc. -30.74 Million USD 99.815%
Biora Therapeutics, Inc. -124.11 Million USD 99.954%
Bio-Path Holdings, Inc. -16.07 Million USD 99.646%
Better Therapeutics, Inc. -39.76 Million USD 99.857%
Calithera Biosciences, Inc. -18.86 Million USD 99.698%
Comera Life Sciences Holdings, Inc. -18.37 Million USD 99.69%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -35.81 Million USD 99.841%
Eloxx Pharmaceuticals, Inc. -36.06 Million USD 99.842%
Evelo Biosciences, Inc. -114.52 Million USD 99.95%
Evolutionary Genomics, Inc. -2.24 Million USD 97.468%
Finch Therapeutics Group, Inc. -74.75 Million USD 99.924%
Galera Therapeutics, Inc. -59.08 Million USD 99.904%
Innovation1 Biotech Inc. -5.98 Million USD 99.049%
Kiromic BioPharma, Inc. -21.29 Million USD 99.733%
Molecular Templates, Inc. -8.12 Million USD 99.299%
Navidea Biopharmaceuticals, Inc. -15.17 Million USD 99.625%
NexImmune, Inc. -32.34 Million USD 99.824%
Orgenesis Inc. -55.36 Million USD 99.897%
Panbela Therapeutics, Inc. -25.26 Million USD 99.775%
Point of Care Nano-Technology, Inc. -78.01 Thousand USD 27.024%
PaxMedica, Inc. Common Stock -18.28 Million USD 99.689%
Scopus BioPharma Inc. -11.6 Million USD 99.51%
Sorrento Therapeutics, Inc. -572.84 Million USD 99.99%
Statera Biopharma, Inc. -174.4 Million USD 99.967%
TRACON Pharmaceuticals, Inc. -3.58 Million USD 98.413%
Trevena, Inc. -40.28 Million USD 99.859%
Vaccinex, Inc. -20.25 Million USD 99.719%
Vicapsys Life Sciences, Inc. -1.18 Million USD 95.184%
Viracta Therapeutics, Inc. -51.05 Million USD 99.888%
ZIVO Bioscience, Inc. -7.77 Million USD 99.268%